Insider · CIK 0001117167
CASAMENTO CHARLES J
Reports to the SEC for 11 companies · DEERPARK, IL
Transactions
50
Companies
11
Filings
18
CIK
0001117167
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-07-31 | ETONEton Pharmaceuticals, Inc. · Common StockA Award | — |
| 2026-01-12 | ETONEton Pharmaceuticals, Inc. · Employee Stock Option (Right to Buy)A Award | — |
| 2026-01-12 | ETONEton Pharmaceuticals, Inc. · Restricted Stock UnitsA Award | — |
| 2025-12-12 | RLMDRELMADA THERAPEUTICS, INC. · Stock Appreciation RightsA Award | — |
| 2025-09-04 | GTBPGT Biopharma, Inc. · Option to purchase Common StockA Award | — |
| 2025-06-26 | RLMDRELMADA THERAPEUTICS, INC. · Stock Option (right to buy)A Award | — |
| 2025-01-03 | ETONEton Pharmaceuticals, Inc. · Employee Stock Option (Right to Buy)A Award | — |
| 2024-10-22 | RLMDRELMADA THERAPEUTICS, INC.G Gift | — |
| 2024-09-09 | RLMDRELMADA THERAPEUTICS, INC.P Purchase | +$33.3K |
| 2024-05-24 | RLMDRELMADA THERAPEUTICS, INC. · Stock Option (right to buy)A Award | — |
| 2024-05-24 | RLMDRELMADA THERAPEUTICS, INC. · Stock Option (right to buy)J Other | — |
| 2024-03-12 | Kuvatris Therapeutics, Inc.F Tax Payment | −$684.48 |
| 2024-02-13 | ETONEton Pharmaceuticals, Inc. · Stock Option (Right to buy)A Award | — |
| 2024-01-29 | Kuvatris Therapeutics, Inc.F Tax Payment | −$73.72 |
| 2024-01-02 | GRDXGridAI Technologies Corp.A Award | — |
| 2023-12-15 | RLMDRELMADA THERAPEUTICS, INC. · Stock Option (right to buy)A Award | — |
| 2023-10-02 | Kuvatris Therapeutics, Inc.F Tax Payment | −$1,869.95 |
| 2023-09-15 | GRDXGridAI Technologies Corp.S Sale | −$4.3 |
| 2023-08-31 | GRDXGridAI Technologies Corp.S Sale | −$1,815.9 |
| 2023-06-16 | GTBPGT Biopharma, Inc. · Option to purchase Common StockA Award | — |
| 2023-05-25 | RLMDRELMADA THERAPEUTICS, INC. · Stock Option (right to buy)A Award | — |
| 2023-04-13 | Kuvatris Therapeutics, Inc.A Award | — |
| 2023-03-03 | ETONEton Pharmaceuticals, Inc. · Stock Option (Right to buy)A Award | — |
| 2023-01-03 | GRDXGridAI Technologies Corp.A Award | — |
| 2022-12-16 | RLMDRELMADA THERAPEUTICS, INC. · Stock Option (right to buy)A Award | — |
| 2022-10-01 | Kuvatris Therapeutics, Inc.A Award | — |
| 2022-05-25 | RLMDRELMADA THERAPEUTICS, INC. · Stock Option (right to buy)A Award | — |
| 2022-04-01 | RLMDRELMADA THERAPEUTICS, INC.S Sale | −$95.7K |
| 2022-04-01 | RLMDRELMADA THERAPEUTICS, INC.M Exercise/Conversion | +$64.2K |
| 2022-04-01 | RLMDRELMADA THERAPEUTICS, INC.S Sale | −$95.7K |
| 2022-04-01 | RLMDRELMADA THERAPEUTICS, INC.S Sale | −$95.7K |
| 2022-04-01 | RLMDRELMADA THERAPEUTICS, INC.S Sale | −$95.7K |
| 2022-04-01 | RLMDRELMADA THERAPEUTICS, INC. · Stock Option (right to buy)M Exercise/Conversion | — |
| 2022-04-01 | RLMDRELMADA THERAPEUTICS, INC.S Sale | −$95.7K |
| 2022-04-01 | RLMDRELMADA THERAPEUTICS, INC.S Sale | −$95.7K |
| 2022-02-07 | ETONEton Pharmaceuticals, Inc. · Stock Option (Right to buy)A Award | — |
| 2022-01-03 | GRDXGridAI Technologies Corp. · Stock option (right to buy)A Award | — |
| 2021-12-17 | RLMDRELMADA THERAPEUTICS, INC. · Stock Option (right to buy)A Award | — |
| 2021-12-03 | RLMDRELMADA THERAPEUTICS, INC.G Gift | — |
| 2021-12-03 | RLMDRELMADA THERAPEUTICS, INC.G Gift | — |
| 2021-09-22 | RLMDRELMADA THERAPEUTICS, INC. · Options to purchase common stockM Exercise/Conversion | — |
| 2021-09-22 | RLMDRELMADA THERAPEUTICS, INC.S Sale | −$40.6K |
| 2021-09-22 | RLMDRELMADA THERAPEUTICS, INC.S Sale | −$95.7K |
| 2021-09-22 | RLMDRELMADA THERAPEUTICS, INC.S Sale | −$55.1K |
| 2021-09-22 | RLMDRELMADA THERAPEUTICS, INC.M Exercise/Conversion | +$46K |
| 2021-08-17 | RLMDRELMADA THERAPEUTICS, INC.M Exercise/Conversion | +$46K |
| 2021-08-17 | RLMDRELMADA THERAPEUTICS, INC. · Options to purchase common stockM Exercise/Conversion | — |
| 2021-07-15 | RLMDRELMADA THERAPEUTICS, INC.S Sale | −$37.8K |
| 2021-07-15 | RLMDRELMADA THERAPEUTICS, INC.S Sale | −$66.3K |
| 2021-06-01 | RLMDRELMADA THERAPEUTICS, INC.S Sale | −$82.3K |
Recent filings
- 4CASAMENTO CHARLES J0001437749-26-025725SEC(opens sec.gov)
- 4CASAMENTO CHARLES J0001437749-26-001296SEC(opens sec.gov)
- 4CASAMENTO CHARLES J0001213900-25-121967SEC(opens sec.gov)
- 4CASAMENTO CHARLES J0001641172-25-026891SEC(opens sec.gov)
- 4CASAMENTO CHARLES J0001213900-25-059867SEC(opens sec.gov)
- 4CASAMENTO CHARLES J0001437749-25-000464SEC(opens sec.gov)
- 4CASAMENTO CHARLES J0001213900-24-089971SEC(opens sec.gov)
- 4CASAMENTO CHARLES J0001213900-24-077794SEC(opens sec.gov)
- 4CASAMENTO CHARLES J0001213900-24-047632SEC(opens sec.gov)
- 4CASAMENTO CHARLES J0001104659-24-034545SEC(opens sec.gov)
- 4CASAMENTO CHARLES J0001437749-24-004363SEC(opens sec.gov)
- 4CASAMENTO CHARLES J0001104659-24-008885SEC(opens sec.gov)
- 4CASAMENTO CHARLES J0001104659-24-001440SEC(opens sec.gov)
- 4CASAMENTO CHARLES J0001213900-23-097024SEC(opens sec.gov)
- 4CASAMENTO CHARLES J0001062993-23-019006SEC(opens sec.gov)
- 4CASAMENTO CHARLES J0001104659-23-101684SEC(opens sec.gov)
- 4CASAMENTO CHARLES J0001104659-23-098422SEC(opens sec.gov)
- 4CASAMENTO CHARLES J0001493152-23-022059SEC(opens sec.gov)
Companies
- Astex Pharmaceuticals, IncDirector
- Eton Pharmaceuticals, Inc.DirectorETON
- GridAI Technologies Corp.DirectorGRDX
- GT Biopharma, Inc.DirectorGTBP
- International Stem Cell CORPDirectorISCO
- Kuvatris Therapeutics, Inc.Director
- LIFEPOINT INCDirector
- QUESTCOR PHARMACEUTICALS INCInsider
- RELMADA THERAPEUTICS, INC.DirectorRLMD
- RespireRx Pharmaceuticals Inc.Director
- VIVUS INCDirector
Address
C/O ETON PHARMACEUTICALS, INC. 21925 W. FIELD PARKWAY, SUITE 235
DEERPARK, IL, 60010-7208